Pyrimethamine Elicits Antitumor Effects on Prostate Cancer by Inhibiting the p38-NF-κB Pathway

Since incurable castration-resistant prostate cancer (CRPC) inevitably develops following treatment with androgen deprivation therapy, there is an urgent need to devise new therapeutic strategies to treat this cancer. Pyrimethamine, an FDA-approved antimalarial drug, is known to exert an antitumor a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xumin, Zhang, Jinming, Hu, Xiaoping, He, Peiqing, Guo, Jianyu, Li, Jun, Lan, Tian, Liu, Jumei, Peng, Lilan, Li, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261869/
https://www.ncbi.nlm.nih.gov/pubmed/32523533
http://dx.doi.org/10.3389/fphar.2020.00758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261869/
https://www.ncbi.nlm.nih.gov/pubmed/32523533
http://dx.doi.org/10.3389/fphar.2020.00758

Ejemplares similares